Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.20.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Total revenues $ 55,761 $ 12,624
Costs and expenses:    
Cost of product sales 155 107
Research and development 16,149 10,949
Selling, general and administrative 18,430 19,946
Total costs and expenses 34,734 31,002
Income (Loss) from operations 21,027 (18,378)
Interest income 358 780
Interest expense (142)  
Net income (loss) $ 21,243 $ (17,598)
Net income (loss) per share, basic and diluted    
Basic (in dollars per share) $ 0.13 $ (0.11)
Diluted (in dollars per share) $ 0.13 $ (0.11)
Weighted average shares used in computing net income (loss) per share    
Basic (in shares) 168,469 167,173
Diluted (in shares) 168,568 167,173
Weighted average shares used in computing net income (loss) per share, basic and diluted (in shares) 168,469 167,173
Product sales, net    
Total revenues $ 12,680 $ 8,054
Contract revenues from collaborations    
Total revenues $ 43,081 $ 4,570